Publications

Selected high impact factor publications:

  1. Coleman KK, Tay DJW, Tan KS, Ong SWX, Than TS, Koh MH, Chin YQ, Nasir H, Mak TM, Chu JJH, Milton DK, Chow VTK, Tambyah PA, Chen M, Tham KW. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing. Clin Infect Dis. 2021 Aug 6;74:1722-1728.
  2. Chan LLY, Gamage AM, Tan CW, Tan KS, Liu J, Tay DJW, Foo RJH, Rénia L, Wang Y, Wang LF. Generation of self-replicating airway organoids from the cave nectar bat Eonycteris spelaea as a model system for studying host-pathogen interactions in the bat airway epithelium. Emerg Microbes Infect. 2022 Dec 12;12(1):e2148561.
  3. Li M, Ren Y, Aw ZQ, Chen B, Yang Z, Lei Y, Cheng L, Liang Q, Hong J, Yang Y, Chen J, Wong YH, Wei J, Shan S, Zhang S, Ge J, Wang R, Dong JZ, Chen Y, Shi X, Zhang Q, Zhang Z, Chu JJH, Wang X, Zhang L. Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses. Nat Commun. 2022 Dec 27;13:7957.
  4. Ju B, Zhang Q, Wang Z, Aw ZQ, Chen P, Zhou B, Wang R, Ge X, Lv Q, Cheng L, Zhang R, Wong YH, Chen H, Wang H, Shan S, Liao X, Shi X, Liu L, Chu JJH, Wang X, Zhang Z, Zhang L. Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants. Nat Immunol. 2023 Mar 13; 24:690-699
  5. Tan KS, Ong SWX, Koh MH, Tay DJW, Aw DZH, Nah YW, Abdullah MR, Coleman KK, Milton DK, Chu JJH, Chow VT, Tambyah PA, Tham KW. SARS-CoV-2 Omicron variant shedding during respiratory activities. Int J Infect Dis. 2023 Mar 20; 131: 19-25.
  6. Jayasinghe MK, Gao C, Yap G, Yeo BZJ, Vu LT, Tay DJW, Loh WX, Aw ZQ, Chen H, Phung DC, Hoang DV, Prajogo RC, Hooi L, Lim FQ, Pirisinu M, Mok CK, Lim KW, Tang SZ, Tan KS, Chow EK, Chen L, Phan AT, Chu JJH, Le MTN. Red blood cell-derived extracellular vesicles display endogenous anti-viral effects and enhance the efficacy of anti-viral oligonucleotide therapy. ACS Nano. 2023; Epub ahead of print.

Other publications:

  1. Shan S, Mok CK, Zhang S, Lan J, Li J, Yang Z, Wang R, Cheng L, Fang M, Aw ZQ, Yu J, Zhang Q, Shi X, Zhang T, Zhang Z, Wang J, Wang X, Chu JJH, Zhang L. A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants. Front Immunol. 2021 Dec 13;12:766821.
  2. Ng YL, Salim CK, Chu JJH. Drug repurposing for COVID-19: Approaches, challenges and promising candidates. Pharmacol Ther. 2021 Dec;228:107930.
  3. Joseph T. (2021). Management system approach for addressing biosafety and biosecurity of emerging pathogens in a biosafety level-3 core facility. Applied Biosafety, Volume 26, Number 40, 2021. https://doi.org/10.1089/apb.2021.0007.
  4. Tay DJW, Lew ZZR, Chu JJH, Tan KS. Uncovering Novel Viral Innate Immune Evasion Strategies: What Has SARS-CoV-2 Taught Us? Front Microbiol. 2022 Mar 23;13:844447.
  5. Wang R, Zhang Q, Zhang R, Aw ZQ, Chen P, Wong YH, Hong J, Ju B, Shi X, Ding Q, Zhang Z, Chu JJH, Zhang L. SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2. Front Immunol. 2022 Jun 17;13:854952.
  6. Aw ZQ, Mok CK, Wong YH, Chen H, Mak TM, Lin RTP, Lye DC, Tan KS, Chu JJH. Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages. Front Immunol. 2022 Oct 27;13:950666.
  7. Tan KS, Ang AXY, Tay DJW, Somani J, Ng AJY, Peng LL, Chu JJH, Tambyah PA, Allen DM. Detection of hospital environment contamination during SARS-CoV-2 Omicron predominance using a highly sensitive air sampling device. Front Public Health. 2023 Jan 10; 10:1067575. 
  8. Mok CK, Ng YL, Ahidjo BA, Aw ZQ, Chen H, Wong YH, Lee RCH, Loe MWC, Liu J, Tan KS, Kaur P, Wang DY, Hao E, Hou X, Tan YW, Deng J, Chu JJH. Evaluation of in-vitro and in-vivo antiviral activities of Vitamin D for SARS CoV-2 and variants. Pharmaceutics. 2023 Mar; 15: 925
  9. Kuroki A, Tay DJW, Chua ACY, Tan, BSY, Li N, Leong J, Tan KS, Wang Y, Tan EWP, Renia L, Hedrick JL, Yang YY, Lee GH. Amphiphilic Sulfonated Polycarbonates Inactivate SARS-CoV-2 in Seconds. Macromolecules. 2023 Aug; 56:6003–6009.

Core Facilities

Contact Us
Top